Concepedia

Mark Selby

MS

Statistics

Publications

80

Citations

14.2K

H-Index

49

Active since

1962

Affiliations

University of California, San Francisco(Current)

Bristol-Myers Squibb (United States)

Ceres Power (United Kingdom)

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Mark Selby is an author at University of California, San Francisco specializing in life sciences, immunology, and molecular biology.

ORCID

Publications per year

1962–2023

80

Publications

80

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2010 · 2.9K citations · Full text

, , +17

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

Seng‐Ryong Woo, Meghan E. Turnis, Monica V. Goldberg et al. · Cancer Research · 2011 · 1.6K citations · Full text

, , +17

Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo

Georg Widera, Melissa A. Austin, Dietmar Rabussay et al. · The Journal of Immunology · 2000 · 601 citations · Full text

, , +17

<i>In Vitro</i> Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and <i>In Vivo</i> Toxicology in Non-Human Primates

Changyu Wang, Kent Thudium, Minhua Han et al. · Cancer Immunology Research · 2014 · 592 citations

, , +17

The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences

Graeme I. Bell, Mark Selby, William J. Rutter · Nature · 1982 · 524 citations

, , +12

1–5 of 80